Syneos Health · 13 hours ago
SVP, Clinical Development
USA-NC-Morrisville-Hybrid
Full-time
Hybrid
Director/Executive
$246K/yr - $454K/yr
15+ years expSyneos Health is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. The Senior Vice President (SVP), Clinical Development – Cardio Metabolic and Intensive Care provides strategic, scientific, and operational leadership across global clinical development programs within the Cardio Metabolic and Intensive Care therapeutic areas, ensuring the successful delivery of complex studies and driving operational excellence.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Directly influences Syneos Health’s success in the Cardio Metabolic and Intensive Care therapeutic areas by ensuring delivery excellence, strengthening client partnerships, and driving innovation across clinical operations
Serves as both a scientific authority and operational leader, shaping the future of clinical delivery and reinforcing Syneos Health’s reputation for excellence and leadership in the global CRO landscape
Develop and execute the strategic vision for Cardio Metabolic and Intensive Care delivery, aligning clinical execution with corporate goals and client expectations
Anticipate emerging trends and therapeutic innovations to position Syneos Health as the preferred partner in these therapeutic areas
Drive organizational strategy for operational excellence, scalability, and delivery modernization
Collaborate closely with senior leaders to align project delivery with enterprise objectives and strategic growth priorities
Maintain fluency in current and emerging clinical standards across cardiovascular, metabolic, and intensive care indications
Act as a recognized thought leader—engaging in high-level discussions with client C-suites, regulatory stakeholders, and industry influencers
Contribute to scientific and clinical development discussions, leveraging evidence-based insights to shape client strategies and partnerships
Represent the company in scientific and industry forums to enhance visibility and credibility
Provide executive oversight of all Cardio Metabolic and Intensive Care projects from early to late development phases
Ensure operational excellence, delivery performance, and proactive risk mitigation across the portfolio
Establish and monitor governance frameworks for performance tracking, escalation management, and continuous improvement
Partner cross-functionally with operational, scientific, and quality leaders to drive consistency and innovation in project delivery
Serve as the senior executive liaison for key strategic clients within the CMIC portfolio
Partner with BD and functional teams to expand client relationships and identify growth opportunities
Support high-stakes client engagements, including bid defenses, RFIs, and strategic presentations; coach senior leaders to do the same
Cultivate long-term partnerships by demonstrating deep therapeutic expertise, strategic insight, and delivery excellence
Maintain accountability for the financial health and performance of the CMIC therapeutic area
Drive forecasting accuracy, portfolio profitability, and efficient resource utilization
Collaborate with finance and operations leaders to ensure sustainable cost management and growth
Champion data-driven decision making using operational analytics and performance metrics
Lead, mentor, and develop a high-performing team of global leaders (VP and below) within the CMIC therapeutic area
Build a culture of collaboration, inclusion, empowerment, accountability, and continuous improvement
Partner with HR and organizational leadership to strengthen succession pipelines and develop next-generation leaders
Ensure compliance with ICH/GCP, regulatory standards, and internal quality systems
Collaborate with quality leadership to drive inspection readiness and consistency across global operations
Lead process improvement initiatives aimed at enhancing efficiency, scalability, and client satisfaction
Model a culture of quality and operational integrity across all delivery teams
Qualification
Required
Advanced degree (MS, PharmD, MD, or equivalent) in Life Sciences, Medicine, Pharmacy, or related scientific discipline required
Minimum of 15+ years of experience in clinical research, project management, or clinical operations within CRO, pharmaceutical, or biotechnology environments
Extensive experience leading complex clinical development programs in cardiology, metabolic disorders, or intensive care indications
Proven ability to manage large, global portfolios and lead multi-layered leadership teams
Strong business acumen and financial management experience (budgeting, forecasting, P&L ownership)
Deep understanding of drug development processes, GCP/ICH guidelines, and global regulatory expectations
Exceptional executive presence with demonstrated ability to influence and engage at C-suite and senior client levels
Strategic thinker with a track record of driving innovation, transformation, and operational excellence
Ability to travel as required (approximately 30–35%)
Preferred
Ph.D. preferred but not required
Benefits
Company car or car allowance
Health benefits to include Medical, Dental and Vision
Company match 401k
Eligibility to participate in Employee Stock Purchase Plan
Eligibility to earn commissions/bonus based on company and individual performance
Flexible paid time off (PTO) and sick time
Company
Syneos Health
Syneos Health, the only fully integrated end-to-end clinical and commercial solution organization.
10001+ employees
H1B Sponsorship
Syneos Health has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (35)
2024 (26)
2023 (49)
2022 (63)
2021 (84)
2020 (63)
Funding
Current Stage
Public CompanyTotal Funding
$524.65M2023-09-28Private Equity
2023-05-10Acquired
2021-03-01Post Ipo Secondary· $524.65M
Leadership Team
Costa Panagos
Chief Executive Officer
Michael Bonello
Executive Vice President and Chief Financial Officer
Recent News
2026-01-09
2025-12-01
Company data provided by crunchbase